Literature DB >> 35657420

Tricuspid Valve Endocarditis in Four Patients with Unrepaired Restrictive Perimembranous Ventricular Septal Defects.

Adam M Butensky1, Alexandra Channing1, Andrew S Handel2, David Kalfa1, Stuart Holzer3.   

Abstract

Congenital heart disease (CHD) is the most common predisposing factor for pediatric infective endocarditis (IE). Although patients with unrepaired ventricular septal defects (VSDs) are at greater risk of IE than those without CHD, the American Heart Association (AHA) considers VSDs to be relatively low risk and therefore does not recommend antibiotic prophylaxis against IE. Even among patients with VSDs who develop IE, current AHA and European Society for Cardiology (ESC) guidelines do not recommend surgical VSD closure, despite the potential for a second IE event. We present a case series of four children with small, restrictive, perimembranous VSDs who developed tricuspid valve (TV) IE. All four experienced delayed diagnosis and secondary complications, including three with septic pulmonary emboli. All four patients ultimately underwent surgical VSD closure. These cases highlight the importance of recognizing IE as a possible cause of prolonged fever in children, even among those with even 'low-risk' CHD. The cases also draw attention to the potential benefits of VSD closure in patients who develop IE.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Endocarditis; Indications for surgery; Septic emboli; Tricuspid valve; Ventricular septal defect

Year:  2022        PMID: 35657420     DOI: 10.1007/s00246-022-02938-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  15 in total

Review 1.  Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association.

Authors:  Robert S Baltimore; Michael Gewitz; Larry M Baddour; Lee B Beerman; Mary Anne Jackson; Peter B Lockhart; Elfriede Pahl; Gordon E Schutze; Stanford T Shulman; Rodney Willoughby
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

2.  Long-Term Outcome of Patients with Perimembranous Ventricular Septal Defect: Results from the Belgian Registry on Adult Congenital Heart Disease.

Authors:  Charlien Gabriels; Julie De Backer; Agnes Pasquet; Bernard P Paelinck; Marielle Morissens; Frederik Helsen; Alexander Van De Bruaene; Werner Budts
Journal:  Cardiology       Date:  2016-09-21       Impact factor: 1.869

3.  High incidence of infective endocarditis in adults with congenital ventricular septal defect.

Authors:  Elisabeth Berglund; Bengt Johansson; Mikael Dellborg; Peder Sörensson; Christina Christersson; Niels-Eric Nielsen; Daniel Rinnström; Ulf Thilén
Journal:  Heart       Date:  2016-07-21       Impact factor: 5.994

4.  Mortality and complications in 3495 children with isolated ventricular septal defects.

Authors:  Jarle Jortveit; Elisabeth Leirgul; Leif Eskedal; Gottfried Greve; Tatiana Fomina; Gaute Døhlen; Grethe S Tell; Sigurd Birkeland; Nina Øyen; Henrik Holmstrøm
Journal:  Arch Dis Child       Date:  2016-04-18       Impact factor: 3.791

5.  Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors.

Authors:  Dinela Rushani; Jay S Kaufman; Raluca Ionescu-Ittu; Andrew S Mackie; Louise Pilote; Judith Therrien; Ariane J Marelli
Journal:  Circulation       Date:  2013-09-24       Impact factor: 29.690

6.  Natural and modified history of isolated ventricular septal defect: a 17-year study.

Authors:  P Frontera-Izquierdo; G Cabezuelo-Huerta
Journal:  Pediatr Cardiol       Date:  1992-10       Impact factor: 1.655

7.  Increased incidence of infective endocarditis in patients with ventricular septal defect.

Authors:  Phong Teck Lee; Felix Maverick Uy; Jie Sheng Foo; Ju Le Tan
Journal:  Congenit Heart Dis       Date:  2018-09-27       Impact factor: 2.007

8.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  Circulation       Date:  2007-04-19       Impact factor: 29.690

9.  Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect.

Authors:  W M Gersony; C J Hayes; D J Driscoll; J F Keane; L Kidd; W M O'Fallon; D R Pieroni; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Behavior of unrepaired perimembranous ventricular septal defect in young adults.

Authors:  Veerle Soufflet; Alexander Van de Bruaene; Els Troost; Marc Gewillig; Philip Moons; Martijn C Post; Werner Budts
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.